News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Marvell's AI networking and optics revenue is accelerating and the company generates positive free cash flow.
  • Marvell still trades at about 50x P/E and 13x P/S, implying a high valuation that could limit near-term upside.
  • Analysts propose a measured mid-term long trade in Marvell to target a re-rating while protecting capital if growth disappoints.
  • Western Digital posted quarter-to-quarter revenue growth.
  • Western Digital showed margin expansion and generated robust free cash flow.
  • Analysts upgraded WDC into an actionable 45-trading-day long trade with defined entry, stop and target.

Latest Articles

Goldman Sachs Sees November 2026 Rate Increase by Bank of England

Goldman Sachs Sees November 2026 Rate Increase by Bank of England

Goldman Sachs has revised its outlook for the Bank of England, now projecting a 25-basis-point rise in the bank rate in November 2026 after recent increases in energy costs, a larger-than-expected uptick in headline inflation and robust growth data. The bank still expects the BoE to hold at 3.75% in September and to pause after a potential November…

BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients

BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients

BioNTech, in collaboration with OncoC4, announced updated Phase 3 trial data showing that their investigational immunotherapy gotistobart significantly improves median overall survival to 18.5 months versus 10.0 months with standard chemotherapy in patients with previously treated squamous non-small cell lung cancer. The therapy's novel mechanism s…

Santander Brasil: A High-Return Bank Worth a Patient Long Trade

Santander Brasil: A High-Return Bank Worth a Patient Long Trade

Banco Santander (Brasil) trades at $6.02 with a $22.97B market cap, a 4.9% yield and improving technicals. The combination of above-average profitability, steady distributions and a supportive technical backdrop makes this a concrete long idea for investors willing to hold through Brazil macro noise for up to 180 trading days.

Markets Wobble as AI Safety Warnings and Hormuz Talks Delay Rattle Investors

Markets Wobble as AI Safety Warnings and Hormuz Talks Delay Rattle Investors

U.S. equity futures fell early Monday after high-level warnings about accelerating artificial intelligence development prompted investors to reassess the outlook for large-scale AI infrastructure spending. The selloff in Asia and Europe followed comments from Anthropic's CEO calling for a deliberate deceleration in frontier model development, suppo…

NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer

NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer

Nanobiotix announced complete safety and efficacy results from the Phase 1 trial evaluating JNJ-1900 (NBTXR3), a radiotherapy-activated nanoparticle, in 24 patients with inoperable, recurrent non-small cell lung cancer. The trial showed no dose-limiting toxicities and clinically meaningful local tumor control at lower re-irradiation doses, with a o…

Regional Diplomacy Delays as Attacks Threaten Two Vital Oil Corridors

Regional Diplomacy Delays as Attacks Threaten Two Vital Oil Corridors

A planned regional meeting to present an Iran-Oman agreement on navigation in the Strait of Hormuz was postponed, while fresh attacks damaged a Saudi east-west pipeline and incidents at sea increased the threat to two of the Middle East's most critical oil transit routes. The combined developments have tightened markets, pushed oil and diesel price…

North Korea Conducts Live-Fire Joint Drill Testing Artillery and Missile Units

North Korea Conducts Live-Fire Joint Drill Testing Artillery and Missile Units

North Korea conducted a live-fire 'joint firepower attack drill' that tested long-range artillery and missile formations, state media reported. The exercise involved five army units and a range of weapons, and was described by an artillery director as intended to raise troop morale and readiness. South Korea's Joint Chiefs of Staff reported that Py…

Buy the Dip in Custom Truck One Source: A Mid-Term Swing Trade on Improving Demand and Oversold Sentiment

Buy the Dip in Custom Truck One Source: A Mid-Term Swing Trade on Improving Demand and Oversold Sentiment

Custom Truck One Source (CTOS) has pulled back from its 52-week high and is trading near technical and fundamental support. The business continues to show revenue growth, an improving operating profile, and an enterprise value that implies reasonable upside if margins and cash flow normalize. This trade idea lays out a concrete entry, stop and targ…

Qualcomm: Market Hasn't Priced the AI Data-Center Pivot

Qualcomm: Market Hasn't Priced the AI Data-Center Pivot

Qualcomm just landed an up-to-$60B AI chip deal with Amazon and is targeting $15B in data-center revenue by 2029. The stock trades at ~$182 with a 21x P/E and generates $10.4B in free cash flow — attractive if you believe Qualcomm can execute the pivot away from smartphones. This trade idea lays out an actionable long with entry, stop, targets, cat…

Broadcom Setup: Position for an AI-Driven Re-acceleration

Broadcom Setup: Position for an AI-Driven Re-acceleration

Broadcom is trading below recent highs while its AI semiconductor revenue and software portfolio are showing accelerating traction. The company screens expensive on headline multiples but delivers massive free cash flow, high ROE and near-term catalysts that could re-rate the stock. This trade plan targets a mid-term run toward $420, with a defined…

Rollins: A High-Quality Pest-Control Franchise at an Attractive Entry

Rollins: A High-Quality Pest-Control Franchise at an Attractive Entry

Rollins (ROL) is a dominant pest-control services platform with recurring revenue, high returns on capital and healthy cash flow. Recent weakness driven by softer digital leads and a disappointing quarter has pulled the stock from its 52-week high and left fundamentals that still look attractive. We present a trade plan to accumulate on weakness wi…